On April 23, we suggested investors take a bullish posture on NVO, the maker of Ozempic (a popular diabetes therapy) and Wegovy (the popular weight loss drug). This article is for paid members - please login or subscribe for access. Username Password Remember Me Forgot Password Share: Mark W. Guthner, CFA Previous Post Apple Inc: AAPLNext PostDollar General: DG You Might Also Like Goldman Sachs: (GS) February 9, 2022 Honda Motor Corporation: HMC September 21, 2023 Investors Hit the Panic Button October 11, 2018
You Might Also Like Goldman Sachs: (GS) February 9, 2022 Honda Motor Corporation: HMC September 21, 2023 Investors Hit the Panic Button October 11, 2018
